The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases

por Liang, Xuan-Bing, Dai, Zhi-Cheng, Zou, Rong, Tang, Ji-Xin, Yao, Cui-Wei
Publicado 2023

Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease

por Dai, Zhi-Cheng, Chen, Jin-Xia, Zou, Rong, Liang, Xuan-Bing, Tang, Ji-Xin, Yao, Cui-Wei
Publicado 2023

The expression of renal Epstein-Barr virus markers in patients with lupus nephritis

por YU, XIAO-XIA, YAO, CUI-WEI, TAO, JING-LI, YANG, CHEN, LUO, MIAN-NA, LI, SHANG-MEI, LIU, HUA-FENG
Publicado 2014

Revisited Cyclophosphamide in the Treatment of Lupus Nephritis

por Quan, Xiao-ying, Chen, Hao-tao, Liang, Si-qin, Yang, Chen, Yao, Cui-wei, Xu, Yong-zhi, Liu, Hua-feng, An, Ning
Publicado 2022

Autophagy in peritoneal fibrosis

por Su, Hong-yong, Yang, Jia-jie, Zou, Rong, An, Ning, Chen, Xiao-cui, Yang, Chen, Yang, Hai-juan, Yao, Cui-wei, Liu, Hua-feng
Publicado 2023

Continuation of immunosuppressive treatment may be necessary in IgA nephropathy patients with remission of proteinuria: Evaluation by repeat renal biopsy

por LUO, MIAN-NA, YAO, CUI-WEI, XU, BI-HUA, XU, YONG-ZHI, LIU, WEI JING, FENG, YONG-MIN, TAO, JING-LI, LIU, HUA-FENG
Publicado 2014